Evidence map›Paper›PMID 16847082›Full record

ReviewClinical microbiology reviews2006

Peptide antimicrobial agents.

Håvard Jenssen, Pamela Hamill, Robert E W Hancock

Abstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 871 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
871citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

871 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Effects of Antimicrobial Peptides on Bacterial Cells.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. A Novel Ocellatin-P1 Isoform fromInternational journal of molecular sciences · 2026
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

811 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Håvard JenssenCentre for Microbial Diseases and Immunity Research, University of British Columbia, Lower Mall Research Station, 232-2259 Lower Mall, Vancouver, British Columbia V6T 1Z4, Canada.
Pamela Hamill
Robert E W Hancock

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial host defense peptides are produced by all complex organisms as well as some microbes and have diverse and complex antimicrobial activities. Collectively these peptides demonstrate a broad range of antiviral and antibacterial activities and modes of action, and it is important to distinguish between direct microbicidal and indirect activities against such pathogens. The structural requirements of peptides for antiviral and antibacterial activities are evaluated in light of the diverse set of primary and secondary structures described for host defense peptides. Peptides with antifungal and antiparasitic activities are discussed in less detail, although the broad-spectrum activities of such peptides indicate that they are important host defense molecules. Knowledge regarding the relationship between peptide structure and function as well as their mechanism of action is being applied in the design of antimicrobial peptide variants as potential novel therapeutic agents.

Indexed as

Antimicrobial Cationic PeptidesAmino Acid SequenceAnimalsAnti-Bacterial AgentsAntifungal AgentsAntiparasitic AgentsAntiviral AgentsCattleDefensinsHumansModels, MolecularMolecular Sequence DataRabbitsAnti-Bacterial AgentsAntifungal AgentsAntimicrobial Cationic PeptidesAntiparasitic AgentsAntiviral AgentsDefensins

Identifiers

PMID16847082
PMCPMC1539102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.